These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes. Lyssenko V, Lupi R, Marchetti P, Del Guerra S, Orho-Melander M, Almgren P, Sjögren M, Ling C, Eriksson KF, Lethagen AL, Mancarella R, Berglund G, Tuomi T, Nilsson P, Del Prato S, Groop L. J Clin Invest; 2007 Aug; 117(8):2155-63. PubMed ID: 17671651 [Abstract] [Full Text] [Related]
3. Association of variants of transcription factor 7-like 2 (TCF7L2) with susceptibility to type 2 diabetes in the Dutch Breda cohort. van Vliet-Ostaptchouk JV, Shiri-Sverdlov R, Zhernakova A, Strengman E, van Haeften TW, Hofker MH, Wijmenga C. Diabetologia; 2007 Jan; 50(1):59-62. PubMed ID: 17031610 [Abstract] [Full Text] [Related]
4. Wnt signaling in pancreatic islets. Liu Z, Habener JF. Adv Exp Med Biol; 2010 Jan; 654():391-419. PubMed ID: 20217507 [Abstract] [Full Text] [Related]
5. TCF7L2 in mouse pancreatic beta cells plays a crucial role in glucose homeostasis by regulating beta cell mass. Takamoto I, Kubota N, Nakaya K, Kumagai K, Hashimoto S, Kubota T, Inoue M, Kajiwara E, Katsuyama H, Obata A, Sakurai Y, Iwamoto M, Kitamura T, Ueki K, Kadowaki T. Diabetologia; 2014 Mar; 57(3):542-53. PubMed ID: 24317852 [Abstract] [Full Text] [Related]
6. Tissue-specific alternative splicing of TCF7L2. Prokunina-Olsson L, Welch C, Hansson O, Adhikari N, Scott LJ, Usher N, Tong M, Sprau A, Swift A, Bonnycastle LL, Erdos MR, He Z, Saxena R, Harmon B, Kotova O, Hoffman EP, Altshuler D, Groop L, Boehnke M, Collins FS, Hall JL. Hum Mol Genet; 2009 Oct 15; 18(20):3795-804. PubMed ID: 19602480 [Abstract] [Full Text] [Related]
7. TCF7L2 is a master regulator of insulin production and processing. Zhou Y, Park SY, Su J, Bailey K, Ottosson-Laakso E, Shcherbina L, Oskolkov N, Zhang E, Thevenin T, Fadista J, Bennet H, Vikman P, Wierup N, Fex M, Rung J, Wollheim C, Nobrega M, Renström E, Groop L, Hansson O. Hum Mol Genet; 2014 Dec 15; 23(24):6419-31. PubMed ID: 25015099 [Abstract] [Full Text] [Related]
8. Type 2 diabetes susceptibility gene TCF7L2 and its role in beta-cell function. Gloyn AL, Braun M, Rorsman P. Diabetes; 2009 Apr 15; 58(4):800-2. PubMed ID: 19336690 [No Abstract] [Full Text] [Related]
9. The transcription factor 7-like 2 gene and increased risk of type 2 diabetes: an update. Lyssenko V. Curr Opin Clin Nutr Metab Care; 2008 Jul 15; 11(4):385-92. PubMed ID: 18541996 [Abstract] [Full Text] [Related]
10. TCF7L2 genetic defect and type 2 diabetes. Cauchi S, Froguel P. Curr Diab Rep; 2008 Apr 15; 8(2):149-55. PubMed ID: 18445358 [Abstract] [Full Text] [Related]
11. Transcription factor 7-like 2 polymorphisms and type 2 diabetes, glucose homeostasis traits and gene expression in US participants of European and African descent. Elbein SC, Chu WS, Das SK, Yao-Borengasser A, Hasstedt SJ, Wang H, Rasouli N, Kern PA. Diabetologia; 2007 Aug 15; 50(8):1621-30. PubMed ID: 17579832 [Abstract] [Full Text] [Related]
12. Single nucleotide transcription factor 7-like 2 (TCF7L2) gene polymorphisms in antiislet autoantibody-negative patients at onset of diabetes. Yu J, Steck AK, Babu S, Yu L, Miao D, McFann K, Hutton J, Eisenbarth GS, Klingensmith G. J Clin Endocrinol Metab; 2009 Feb 15; 94(2):504-10. PubMed ID: 19050058 [Abstract] [Full Text] [Related]
13. TCF7L2 and type 2 diabetes--we WNT to know. Smith U. Diabetologia; 2007 Jan 15; 50(1):5-7. PubMed ID: 17102948 [No Abstract] [Full Text] [Related]
14. TCF7L2 polymorphisms are associated with type 2 diabetes in Khatri Sikhs from North India: genetic variation affects lipid levels. Sanghera DK, Nath SK, Ortega L, Gambarelli M, Kim-Howard X, Singh JR, Ralhan SK, Wander GS, Mehra NK, Mulvihill JJ, Kamboh MI. Ann Hum Genet; 2008 Jul 15; 72(Pt 4):499-509. PubMed ID: 18397358 [Abstract] [Full Text] [Related]
16. The transcription factor 7-like 2 (TCF7L2) gene is associated with Type 2 diabetes in UK community-based cases, but the risk allele frequency is reduced compared with UK cases selected for genetic studies. De Silva NM, Steele A, Shields B, Knight B, Parnell K, Weedon MN, Hattersley AT, Frayling TM. Diabet Med; 2007 Oct 15; 24(10):1067-72. PubMed ID: 17725629 [Abstract] [Full Text] [Related]
20. The Wnt signaling pathway effector TCF7L2 and type 2 diabetes mellitus. Jin T, Liu L. Mol Endocrinol; 2008 Nov 15; 22(11):2383-92. PubMed ID: 18599616 [Abstract] [Full Text] [Related] Page: [Next] [New Search]